Abstract:Purpose of review
Neutrophils have traditionally been viewed in the context of acute infection and inflammation forming the first line of defence against invading pathogens. Neutrophil trafficking to the site of inflammation requires adhesion and transmigration through blood vessels, which is orchestrated by adhesion molecules, such as β2- and β1-integrins, chemokines and cytokines. This review focuses on recent advances in understanding the regulators of neutrophil recruitment during inflammation in both acut… Show more
“…Expression levels of the 2 most prominent leukocyte integrins, β 1 and β 2 , were analyzed in the myeloid and lymphoid compartments of the bone marrow of JAK2 +/+ (Cre + ) and JAK2 +/VF (Cre + ) mice. β 1 (CD29) integrin expression was unchanged in granulocytes of JAK2 +/VF compared with JAK2 +/+ mice, corroborating previously published results in human granulocytes isolated from JAK2-and inflammation (18)(19)(20)(21)(22)(23). Two major integrin β-chains, β 1 and β 2 , are expressed on leukocytes, forming either VLA-4 (very late antigen-4) or LFA-1 (lymphocyte function-associated antigen-1) (19).…”
Section: Resultssupporting
confidence: 89%
“…Thus, our findings identified cross-talk between JAK2-V617F and integrin activation promoting pathologic thrombosis and abnormal trafficking of leukocytes to the spleen. JAK2-V617F promotes venous thrombosis through β 1 /β 2 integrin activation migration across the physical endothelium/extracellular matrix (ECM) barrier, and homing of leukocytes into tissues (18)(19)(20)(21)(22)(23). We hypothesized that abnormal function of integrins on leukocytes, in particular neutrophils, may induce abnormal leukocyte-endothelium interaction and thus may contribute to pathologic thrombosis in CMN.…”
JAK2-V617F-positive chronic myeloproliferative neoplasia (CMN) commonly displays dysfunction of integrins and adhesion molecules expressed on platelets, erythrocytes, and leukocytes. However, the mechanism by which the 2 major leukocyte integrin chains, β1 and β2, may contribute to CMN pathophysiology remained unclear. β1 (α4β1; VLA-4) and β2 (αLβ2; LFA-1) integrins are essential regulators for attachment of leukocytes to endothelial cells. We here showed enhanced adhesion of granulocytes from mice with JAK2-V617F knockin (JAK2+/VF mice) to vascular cell adhesion molecule 1- (VCAM1-) and intercellular adhesion molecule 1-coated (ICAM1-coated) surfaces. Soluble VCAM1 and ICAM1 ligand binding assays revealed increased affinity of β1 and β2 integrins for their respective ligands. For β1 integrins, this correlated with a structural change from the low- to the high-affinity conformation induced by JAK2-V617F. JAK2-V617F triggered constitutive activation of the integrin inside-out signaling molecule Rap1, resulting in translocation toward the cell membrane. Employing a venous thrombosis model, we demonstrated that neutralizing anti-VLA-4 and anti-β2 integrin antibodies suppress pathologic thrombosis as observed in JAK2+/VF mice. In addition, aberrant homing of JAK2+/VF leukocytes to the spleen was inhibited by neutralizing anti-β2 antibodies and by pharmacologic inhibition of Rap1. Thus, our findings identified cross-talk between JAK2-V617F and integrin activation promoting pathologic thrombosis and abnormal trafficking of leukocytes to the spleen.
“…Expression levels of the 2 most prominent leukocyte integrins, β 1 and β 2 , were analyzed in the myeloid and lymphoid compartments of the bone marrow of JAK2 +/+ (Cre + ) and JAK2 +/VF (Cre + ) mice. β 1 (CD29) integrin expression was unchanged in granulocytes of JAK2 +/VF compared with JAK2 +/+ mice, corroborating previously published results in human granulocytes isolated from JAK2-and inflammation (18)(19)(20)(21)(22)(23). Two major integrin β-chains, β 1 and β 2 , are expressed on leukocytes, forming either VLA-4 (very late antigen-4) or LFA-1 (lymphocyte function-associated antigen-1) (19).…”
Section: Resultssupporting
confidence: 89%
“…Thus, our findings identified cross-talk between JAK2-V617F and integrin activation promoting pathologic thrombosis and abnormal trafficking of leukocytes to the spleen. JAK2-V617F promotes venous thrombosis through β 1 /β 2 integrin activation migration across the physical endothelium/extracellular matrix (ECM) barrier, and homing of leukocytes into tissues (18)(19)(20)(21)(22)(23). We hypothesized that abnormal function of integrins on leukocytes, in particular neutrophils, may induce abnormal leukocyte-endothelium interaction and thus may contribute to pathologic thrombosis in CMN.…”
JAK2-V617F-positive chronic myeloproliferative neoplasia (CMN) commonly displays dysfunction of integrins and adhesion molecules expressed on platelets, erythrocytes, and leukocytes. However, the mechanism by which the 2 major leukocyte integrin chains, β1 and β2, may contribute to CMN pathophysiology remained unclear. β1 (α4β1; VLA-4) and β2 (αLβ2; LFA-1) integrins are essential regulators for attachment of leukocytes to endothelial cells. We here showed enhanced adhesion of granulocytes from mice with JAK2-V617F knockin (JAK2+/VF mice) to vascular cell adhesion molecule 1- (VCAM1-) and intercellular adhesion molecule 1-coated (ICAM1-coated) surfaces. Soluble VCAM1 and ICAM1 ligand binding assays revealed increased affinity of β1 and β2 integrins for their respective ligands. For β1 integrins, this correlated with a structural change from the low- to the high-affinity conformation induced by JAK2-V617F. JAK2-V617F triggered constitutive activation of the integrin inside-out signaling molecule Rap1, resulting in translocation toward the cell membrane. Employing a venous thrombosis model, we demonstrated that neutralizing anti-VLA-4 and anti-β2 integrin antibodies suppress pathologic thrombosis as observed in JAK2+/VF mice. In addition, aberrant homing of JAK2+/VF leukocytes to the spleen was inhibited by neutralizing anti-β2 antibodies and by pharmacologic inhibition of Rap1. Thus, our findings identified cross-talk between JAK2-V617F and integrin activation promoting pathologic thrombosis and abnormal trafficking of leukocytes to the spleen.
“…A growing body of research suggests that β2 integrins play an important role in tolerance induction [247][248][249] and suppression of inflammation [83,250,251]. Already decades ago, it was noted that LAD-I patients suffer not only from bacterial infections but also from renal or intestinal autoimmune diseases [252,253], and some of them presented type 1 diabetes or autoimmune cytopenia after hematopoietic stem cell transplantation [254].…”
Section: Functions Of β2 Integrins In Autoimmunitymentioning
β2 integrins are heterodimeric surface receptors composed of a variable α (CD11a-CD11d) and a constant β (CD18) subunit and are specifically expressed by leukocytes. The α subunit defines the individual functional properties of the corresponding β2 integrin, but all β2 integrins show functional overlap. They mediate adhesion to other cells and to components of the extracellular matrix (ECM), orchestrate uptake of extracellular material like complement-opsonized pathogens, control cytoskeletal organization, and modulate cell signaling. This review aims to delineate the tremendous role of β2 integrins for immune functions as exemplified by the phenotype of LAD-I (leukocyte adhesion deficiency 1) patients that suffer from strong recurrent infections. These immune defects have been largely attributed to impaired migratory and phagocytic properties of polymorphonuclear granulocytes. The molecular base for this inherited disease is a functional impairment of β2 integrins due to mutations within the CD18 gene. LAD-I patients are also predisposed for autoimmune diseases. In agreement, polymorphisms within the CD11b gene have been associated with autoimmunity. Consequently, β2 integrins have received growing interest as targets in the treatment of autoimmune diseases. Moreover, β2 integrin activity on leukocytes has been implicated in tumor development.
“…Specifically, the interaction of integrins LFA-1 and Mac-1 with ICAM-1 enables neutrophil crawling onto pericytes in the context of extravasation through the venular wall [42]. Finally, a3b1 (CD49c/CD29) integrin and its interacting ligands were recently shown to promote neutrophil extravasation in sepsis [43,44].…”
Section: Integrins Control Leukocyte Recruitment During the Initiatiomentioning
Integrins constitute a large group of adhesion receptors that are formed as heterodimers of α and β subunits. Their presence and activation status on the surface of leukocytes modulate a broad spectrum of processes in inflammation and immunity. This mini review critically outlines research advances with regard to the function of leukocyte integrins in regulating and integrating the onset and resolution of acute inflammation. Specifically, we summarize and discuss relevant, current literature that supports the multifunctional role of integrins and their partners. The latter include molecules that physically associate with integrins or regulate their activity in the context of the following: 1) leukocyte recruitment to an inflamed tissue, 2) recognition and phagocytosis of apoptotic neutrophils (efferocytosis), and 3) egress of efferocytic macrophages from the inflamed site to lymphoid tissues. The understanding of the fine-tuning mechanisms of the aforementioned processes by integrins and their functional partners may enable the design of therapeutic tools to counteract destructive inflammation and promote more efficient resolution of inflammation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.